The central vascular access devices market is set to experience relatively modest growth from around $1.9 billion in 2015 to just over $2.3 billion by 2022, representing a Compound Annual Growth Rate (CAGR) of 2.6%, according to research report.
Latest report states that this growth, which will occur across the 10 major markets (10MM) of US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India, will be driven by a number of factors such as increases in the number of people in the treatment pool across the majority of the 10MM, high growth in central catheter placement, and healthcare providers in areas such as China and India seeking to match treatment regimens in leading markets.
Get sample today at https://marketreportscenter.com/request-sample/442480
Vascular access device is a broad term given to a range of instruments used to aid medical therapies. These instruments most commonly come in the form of thin and flexible catheters that are designed to intravenously deliver medication, nutrition, and fluids, and withdraw blood samples for further testing from large veins.
Amen Sanghera, MSc, our Analyst covering Medical Devices, states that: “China and India will be responsible for a substantial proportion of the vascular access devices market growth over the forecast period, with CAGRs of 4.4% and 2.2% respectively. The European market, however, will see slow growth, with all five European countries registering CAGRs of less than 1%.
“Developing nations are growing in financial power and population size, and these two countries are destined to become financial superpowers in the future, which would enable them to provide healthcare that rivals that of the western world.”
In addition to growing financial power, the developing world will also see its vascular access devices space driven by an increase in major cancers. Indeed, as the developing world adopts Western lifestyles, they are also starting to inherit the caveats of that lifestyle, which include high-calorie diets, high tobacco consumption, and physical inactivity. This has resulted in the prevalence of lung and colon cancer in some countries, with incidences of lung cancer in China surpassing that of the US.
Check the discount at https://marketreportscenter.com/request-discount/442480
Sangera concludes: “Although China and India will increase their respective shares of the central vascular access devices market over the forecast period, the US will continue to dominate, with its share slipping slightly from 40.7% in 2015 to 39.0% by 2022. Indeed, increasing health burdens in the region will ensure steady growth to 2022.”
This report provides analysis of the central vascular access devices space across the 10 major countries of US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India. It includes annualized market data from 2015 and forecast to 2022.
This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by our team of industry experts.
For more details of report, table of content, purchase copy of report visit https://marketreportscenter.com/reports/442480/medipoint-central-vascular-access-devices-global-analysis-and-market-forecasts
You can also reach me if you have any questions or need any assistance
Market Reports Center